Search Results
Oct 02, 2025, 08:08 ET Eisai Highlights Breadth of Oncology Research at ESMO 2025, Featuring 5-Year Survival Data from Study 309/KEYNOTE-775
Final analysis of lenvatinib + pembrolizumab(L+P) vs sunitinib (S) in patients with advanced renal cell carcinoma (aRCC) withor without bone metastases in CLEAR
More news about: Eisai Inc.
Sep 10, 2025, 09:00 ET BlockSpaces Joins Bitcoin for Corporations, Advancing Institutional Bitcoin Finance
enables institutions and treasuries to use Bitcoin as programmable collateral through its flagship product, ARCC (Auto-Reconciled Collateral Contracts). ARCC automates the execution of Bitcoin-backed contracts such as loans, forwards, and derivatives using Bitcoin-native
More news about: BlockSpaces
May 28, 2025, 09:00 ET BlockSpaces Secures $2M to Launch Bitcoin-native Collateral and Risk Management Platform
$10 million and will fuel the launch of ARCC (Auto Reconciled Collateral Contracts), the first Bitcoin-native collateral and risk management platform for institutions. ARCC supports a variety of high-volume Bitcoin-backed
More news about: BlockSpaces